VRCA – verrica pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at Wall
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Wall S
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Verrica Pharmaceuticals (NASDAQ:VRCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Form 3/A Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC
Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC
Form 3 Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC
Form 4 Verrica Pharmaceuticals For: Dec 23 Filed by: Kirby John J.
Form SCHEDULE 13D/A Verrica Pharmaceuticals Filed by: Caligan Partners LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.